NS

Nikhil Subhash Aher

Active Director Designated Partner DIN 10146277
DIN 10146277 First appointment May 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Nikhil Subhash Aher

Data last updated:

Nikhil Subhash Aher is a Designated Partner at Curanest Pharma Llp (since 2023). The company operates in Business Services.

DIN 10146277
Primary Designation Designated Partner
Industry Business Services
First Appointment 03 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 May 20232023Active

Board colleagues of Nikhil Subhash Aher

NameDINCompanyDesignation
Geeta Tushar Deore10146278Curanest Pharma LlpDesignated Partner
Sudhir Bhikaji Bhambar10146276Curanest Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curanest Pharma Llp
Premium access

Shareholding and investment profile for Nikhil Subhash Aher

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikhil Subhash Aher

Nikhil Subhash Aher currently holds 1 directorship: Curanest Pharma Llp (Designated Partner, since 03 May 2023).

Nikhil Subhash Aher was first appointed on 03 May 2023 as Designated Partner at Curanest Pharma Llp.

The current boards of Nikhil Subhash Aher's companies include Geeta Tushar Deore (Curanest Pharma Llp), Sudhir Bhikaji Bhambar (Curanest Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available